Norelgestromin

This classification denotes a therapeutic progestin with the molecular formula C21H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R0TAY3X631, chemically known as 18,19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (8-alpha,9-beta,10-alpha,13-alpha,14-beta)- but generally known as norelgestromin, which bears US NIH Compound Identifier 62930. European Medicines Agency schedules Norelgestromin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20476. The term NORELGESTROMIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 1, 2001, List 45). Most nations schedule norelgestromin under HS 29372900 and SITC 54153. As of Q4 2014, NORELGESTROMIN remains the US FDA Preferred Term for this commodity. Norelgestromin bears US NLM identifiers UMLS ID C1120952 and NCI Concept Code C66243. SMILES: OC1(C2(C(C3C(CC2)C2C(=CC(=N\O)\CC2)CC3)CC1)CC)C#C.